Eduardo Rene Salas - Apr 20, 2022 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
Director
Signature
/s/ Lawrence J. Hineline, Attorney-in-fact
Stock symbol
ITCI
Transactions as of
Apr 20, 2022
Transactions value $
$0
Form type
4
Date filed
4/21/2022, 04:54 PM
Next filing
Jun 13, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITCI Stock Option (right to buy) Award $0 +20K $0.00 20K Apr 20, 2022 Common Stock 20K $60.03 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.